Brought to you by 
Bayer sells Bayer Diabetes Care business to Panasonic Healthcare Holdings
18 Sep 2017
Executive Summary
Bayer AG divested its Bayer Diabetes Care business to manufacturing partner Panasonic Healthcare Holdings Co. Ltd. for approximately $1.1bn (Y138bn). The transaction is expected to close in Q1 2016. Bayer plans to use the proceeds for investments and acquisitions in health care, veterinary and crop protection products.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bayer sells Bayer Diabetes Care business to Panasonic Healthcare Holdings
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice